Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance
- Author
- DONGLIANG GE1 ; FELLAY, Jacques1 ; SULKOWSKI, Mark4 ; MCHUTCHISON, John G2 ; GOLDSTEIN, David B1 ; THOMPSON, Alexander J2 ; SIMON, Jason S3 ; SHIANNA, Kevin V1 ; URBAN, Thomas J1 ; HEINZEN, Erin L1 ; PING QIU3 ; BERTELSEN, Arthur H3 ; MUIR, Andrew J2
[1] Institute for Genome Sciences & Policy, Center for Human Genome Variation, Duke University, Durham, North Carolina 27708, United States
[2] Duke Clinical Research Institute and Division of Gastroenterology, School of Medicine, Duke University, Durham, North Carolina 27705, United States
[3] Schering-Plough Research Institute, Kenilworth, New Jersey 07033, United States
[4] Johns Hopkins University School of Medicine, Baltimore, Maryland 21205, United States - Source
Nature (London). 2009, Vol 461, Num 7262, pp 399-401, 3 p ; ref : 19 ref
- CODEN
- NATUAS
- ISSN
- 0028-0836
- Scientific domain
- Multidisciplinary
- Publisher
- Nature Publishing Group, London
- Publication country
- United Kingdom
- Document type
- Article
- Language
- English
- Keyword (fr)
- Afro Américain Antiviral Caucasoïde Efficacité traitement Hépatite virale C Immunomodulateur Marqueur génétique Peginterféron alfa-2a Peginterféron alfa-2b Polymorphisme Race Ribavirine Traitement Variabilité génétique Virus hépatite C Interféron lambda Etats-Unis Analogue de nucléoside Ethnie Flaviviridae Forme pégylée Hepacivirus Infection Interféron alpha 2a Interféron alpha 2b Pathologie de l'appareil digestif Pathologie du foie Virose Virus Amérique du Nord Amérique
- Keyword (en)
- African American Antiviral Caucasoid Treatment efficiency Viral hepatitis C Immunomodulator Genetic marker Peginterferon alfa-2a Peginterferon alfa-2b Polymorphism Race Ribavirin Treatment Genetic variability Hepatitis C virus Lambda interferon United States Nucleoside analog Ethnic group Flaviviridae Pegylated form Hepacivirus Infection Interferon alpha 2a Interferon alpha 2b Digestive diseases Hepatic disease Viral disease Virus North America America
- Keyword (es)
- Afroamericano Antiviral Caucásico Eficacia tratamiento Hepatítis virica C Inmunomodulador Marcador genético Peginterferón alfa-2a Peginterferón alfa-2b Polimorfismo Raza Ribavirina Tratamiento Variabilidad genética Hepatitis C virus Estados Unidos Análogo nucleósido Etnia Flaviviridae Forma pegilada Hepacivirus Infección Interferon alfa 2a Interferon alfa 2b Aparato digestivo patología Hígado patología Virosis Virus America del norte America
- Classification
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B02 Pharmacology. Drug treatments / 002B02S Antibiotics. Antiinfectious agents. Antiparasitic agents / 002B02S05 Antiviral agents
- Discipline
- Pharmacological treatments
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 21901345
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Access to the document
Install on your browser
DOI
10.1038/nature08309 
https://dx.doi.org/10.1038/nature08309
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:19:\"10.1038\/nature08309\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:81:\"Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance\";s:9:\"\u0000*\u0000jtitle\";s:15:\"Nature (London)\";s:9:\"\u0000*\u0000stitle\";s:14:\"Nature (Lond.)\";s:7:\"\u0000*\u0000date\";s:4:\"2009\";s:9:\"\u0000*\u0000volume\";s:3:\"461\";s:8:\"\u0000*\u0000issue\";s:4:\"7262\";s:8:\"\u0000*\u0000spage\";s:3:\"399\";s:8:\"\u0000*\u0000epage\";s:3:\"401\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0028-0836\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:12:\"DONGLIANG GE\";s:10:\"\u0000*\u0000aufirst\";s:0:\"\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:12:{i:0;s:15:\"FELLAY, Jacques\";i:1;s:15:\"SULKOWSKI, Mark\";i:2;s:19:\"MCHUTCHISON, John G\";i:3;s:18:\"GOLDSTEIN, David B\";i:4;s:21:\"THOMPSON, Alexander J\";i:5;s:14:\"SIMON, Jason S\";i:6;s:16:\"SHIANNA, Kevin V\";i:7;s:15:\"URBAN, Thomas J\";i:8;s:15:\"HEINZEN, Erin L\";i:9;s:8:\"PING QIU\";i:10;s:19:\"BERTELSEN, Arthur H\";i:11;s:14:\"MUIR, Andrew J\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"NATUAS\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:81:\"Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance\";s:8:\"\u0000*\u0000place\";s:6:\"London\";s:6:\"\u0000*\u0000pub\";s:23:\"Nature Publishing Group\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"3\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:19:\"10.1038\/nature08309\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:81:\"Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance\";s:9:\"\u0000*\u0000jtitle\";s:15:\"Nature (London)\";s:9:\"\u0000*\u0000stitle\";s:14:\"Nature (Lond.)\";s:7:\"\u0000*\u0000date\";s:4:\"2009\";s:9:\"\u0000*\u0000volume\";s:3:\"461\";s:8:\"\u0000*\u0000issue\";s:4:\"7262\";s:8:\"\u0000*\u0000spage\";s:3:\"399\";s:8:\"\u0000*\u0000epage\";s:3:\"401\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0028-0836\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:12:\"DONGLIANG GE\";s:10:\"\u0000*\u0000aufirst\";s:0:\"\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:12:{i:0;s:15:\"FELLAY, Jacques\";i:1;s:15:\"SULKOWSKI, Mark\";i:2;s:19:\"MCHUTCHISON, John G\";i:3;s:18:\"GOLDSTEIN, David B\";i:4;s:21:\"THOMPSON, Alexander J\";i:5;s:14:\"SIMON, Jason S\";i:6;s:16:\"SHIANNA, Kevin V\";i:7;s:15:\"URBAN, Thomas J\";i:8;s:15:\"HEINZEN, Erin L\";i:9;s:8:\"PING QIU\";i:10;s:19:\"BERTELSEN, Arthur H\";i:11;s:14:\"MUIR, Andrew J\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"NATUAS\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:81:\"Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance\";s:8:\"\u0000*\u0000place\";s:6:\"London\";s:6:\"\u0000*\u0000pub\";s:23:\"Nature Publishing Group\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"3\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"UnpaywallOpenUrl\":35:{s:8:\"\u0000*\u0000email\";s:27:\"assistance-portail@inist.fr\";s:6:\"\u0000*\u0000fmt\";N;s:6:\"\u0000*\u0000doi\";s:19:\"10.1038\/nature08309\";s:6:\"\u0000*\u0000pii\";N;s:7:\"\u0000*\u0000pmid\";N;s:9:\"\u0000*\u0000atitle\";N;s:9:\"\u0000*\u0000jtitle\";N;s:9:\"\u0000*\u0000stitle\";N;s:7:\"\u0000*\u0000date\";N;s:9:\"\u0000*\u0000volume\";N;s:8:\"\u0000*\u0000issue\";N;s:8:\"\u0000*\u0000spage\";N;s:8:\"\u0000*\u0000epage\";N;s:8:\"\u0000*\u0000pages\";N;s:7:\"\u0000*\u0000issn\";N;s:8:\"\u0000*\u0000eissn\";N;s:9:\"\u0000*\u0000aulast\";N;s:10:\"\u0000*\u0000aufirst\";N;s:9:\"\u0000*\u0000auinit\";N;s:10:\"\u0000*\u0000auinitm\";N;s:5:\"\u0000*\u0000au\";N;s:9:\"\u0000*\u0000aucorp\";N;s:7:\"\u0000*\u0000isbn\";N;s:8:\"\u0000*\u0000coden\";N;s:8:\"\u0000*\u0000genre\";N;s:7:\"\u0000*\u0000part\";N;s:9:\"\u0000*\u0000btitle\";N;s:8:\"\u0000*\u0000title\";N;s:8:\"\u0000*\u0000place\";N;s:6:\"\u0000*\u0000pub\";N;s:10:\"\u0000*\u0000edition\";N;s:9:\"\u0000*\u0000tpages\";N;s:9:\"\u0000*\u0000series\";N;s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";N;}"
Unpaywall access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:19:\"10.1038\/nature08309\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:81:\"Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance\";s:9:\"\u0000*\u0000jtitle\";s:15:\"Nature (London)\";s:9:\"\u0000*\u0000stitle\";s:14:\"Nature (Lond.)\";s:7:\"\u0000*\u0000date\";s:4:\"2009\";s:9:\"\u0000*\u0000volume\";s:3:\"461\";s:8:\"\u0000*\u0000issue\";s:4:\"7262\";s:8:\"\u0000*\u0000spage\";s:3:\"399\";s:8:\"\u0000*\u0000epage\";s:3:\"401\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0028-0836\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:12:\"DONGLIANG GE\";s:10:\"\u0000*\u0000aufirst\";s:0:\"\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:12:{i:0;s:15:\"FELLAY, Jacques\";i:1;s:15:\"SULKOWSKI, Mark\";i:2;s:19:\"MCHUTCHISON, John G\";i:3;s:18:\"GOLDSTEIN, David B\";i:4;s:21:\"THOMPSON, Alexander J\";i:5;s:14:\"SIMON, Jason S\";i:6;s:16:\"SHIANNA, Kevin V\";i:7;s:15:\"URBAN, Thomas J\";i:8;s:15:\"HEINZEN, Erin L\";i:9;s:8:\"PING QIU\";i:10;s:19:\"BERTELSEN, Arthur H\";i:11;s:14:\"MUIR, Andrew J\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"NATUAS\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:81:\"Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance\";s:8:\"\u0000*\u0000place\";s:6:\"London\";s:6:\"\u0000*\u0000pub\";s:23:\"Nature Publishing Group\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"3\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:11:\"BaseOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:19:\"10.1038\/nature08309\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:81:\"Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance\";s:9:\"\u0000*\u0000jtitle\";s:15:\"Nature (London)\";s:9:\"\u0000*\u0000stitle\";s:14:\"Nature (Lond.)\";s:7:\"\u0000*\u0000date\";s:4:\"2009\";s:9:\"\u0000*\u0000volume\";s:3:\"461\";s:8:\"\u0000*\u0000issue\";s:4:\"7262\";s:8:\"\u0000*\u0000spage\";s:3:\"399\";s:8:\"\u0000*\u0000epage\";s:3:\"401\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0028-0836\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:12:\"DONGLIANG GE\";s:10:\"\u0000*\u0000aufirst\";s:0:\"\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:12:{i:0;s:15:\"FELLAY, Jacques\";i:1;s:15:\"SULKOWSKI, Mark\";i:2;s:19:\"MCHUTCHISON, John G\";i:3;s:18:\"GOLDSTEIN, David B\";i:4;s:21:\"THOMPSON, Alexander J\";i:5;s:14:\"SIMON, Jason S\";i:6;s:16:\"SHIANNA, Kevin V\";i:7;s:15:\"URBAN, Thomas J\";i:8;s:15:\"HEINZEN, Erin L\";i:9;s:8:\"PING QIU\";i:10;s:19:\"BERTELSEN, Arthur H\";i:11;s:14:\"MUIR, Andrew J\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"NATUAS\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:81:\"Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance\";s:8:\"\u0000*\u0000place\";s:6:\"London\";s:6:\"\u0000*\u0000pub\";s:23:\"Nature Publishing Group\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"3\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Base Search access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:19:\"10.1038\/nature08309\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:81:\"Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance\";s:9:\"\u0000*\u0000jtitle\";s:15:\"Nature (London)\";s:9:\"\u0000*\u0000stitle\";s:14:\"Nature (Lond.)\";s:7:\"\u0000*\u0000date\";s:4:\"2009\";s:9:\"\u0000*\u0000volume\";s:3:\"461\";s:8:\"\u0000*\u0000issue\";s:4:\"7262\";s:8:\"\u0000*\u0000spage\";s:3:\"399\";s:8:\"\u0000*\u0000epage\";s:3:\"401\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0028-0836\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:12:\"DONGLIANG GE\";s:10:\"\u0000*\u0000aufirst\";s:0:\"\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:12:{i:0;s:15:\"FELLAY, Jacques\";i:1;s:15:\"SULKOWSKI, Mark\";i:2;s:19:\"MCHUTCHISON, John G\";i:3;s:18:\"GOLDSTEIN, David B\";i:4;s:21:\"THOMPSON, Alexander J\";i:5;s:14:\"SIMON, Jason S\";i:6;s:16:\"SHIANNA, Kevin V\";i:7;s:15:\"URBAN, Thomas J\";i:8;s:15:\"HEINZEN, Erin L\";i:9;s:8:\"PING QIU\";i:10;s:19:\"BERTELSEN, Arthur H\";i:11;s:14:\"MUIR, Andrew J\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"NATUAS\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:81:\"Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance\";s:8:\"\u0000*\u0000place\";s:6:\"London\";s:6:\"\u0000*\u0000pub\";s:23:\"Nature Publishing Group\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"3\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
